Author

I. Garcia-Cao

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

T. H. Stracker· 2 shared B. Raught· 1 shared B. Terre· 1 shared C. S. Attolini· 1 shared E. Coyaud· 1 shared F. Supek· 1 shared G. Gil-Gomez· 1 shared G. Piergiovanni· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

T. H. Stracker

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GEMC1 and MCIDAS interactions with SWI/SNF complexes regulate the multiciliated cell-specific transcriptional program

M. Lewis, B. Terre, P. A. Knobel, T. Cheng, H. Lu, C. S. Attolini, J. Smak, E. Coyaud, I. Garcia-Cao, J. Querol, G. Gil-Gomez, G. Piergiovanni, V. Costanzo, S. Peiro, B. Raught, , T. H. Stracker

This study identifies distinct interactions of GEMC1 and MCIDAS with SWI/SNF subcomplexes in multiciliated cell differentiation and shows that these interactions are required for MCC-specific transcriptional regulation.

bioRxiv · Dec 2, 2022 · PreprintCell Biology

Loss of HMCES is synthetic lethal with APOBEC activity in cancer cells

J. Biayna, I. Garcia-Cao, M. M. Alvarez, M. Salvadores, J. Espinosa-Carrasco, M. McCullough, F. Supek, T. H. Stracker

The paper identifies HMCES as a synthetic lethal partner of APOBEC3A in cancer cells, showing its role in protecting against DNA damage and its potential as a therapeutic target.

bioRxiv · Feb 5, 2021 · PreprintCancer Biology